Oric Pharmaceuticals Balance Sheet
NASDAQ: ORICHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Oric Pharmaceuticals financial position
At the end of fiscal 2025, Oric Pharmaceuticals reported total assets of $408.9 million, up 49.2% from a year earlier against total liabilities of $24.5 million. Shareholders' equity stood at $384.4 million, or 94.0% of assets. The company held $45.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 14.13, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Oric Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 45.67M | 59.41M | 23.38M | 66.84M | 226.01M | 78.45M | 89.16M | 42.64M |
| Short-Term Investments | 235.82M | 196.55M | 184.80M | 139.43M | 10.97M | 215.15M | — | — |
| Total Current Assets | 288.47M | 262.25M | 212.60M | 210.46M | 240.52M | 296.70M | 90.00M | — |
| Property, Plant & Equipment | 2.42M | 2.92M | 2.86M | 3.25M | 2.41M | 1.98M | 2.24M | — |
| Long-Term Investments | 110.76M | 0 | 26.85M | 21.95M | 43.39M | 0 | — | — |
| Total Assets | 408.89M | 274.14M | 252.01M | 247.18M | 298.64M | 299.00M | 94.09M | — |
| Accounts Payable | 3.82M | 1.55M | 944.00K | 1.32M | 1.89M | 757.00K | 152.00K | — |
| Total Current Liabilities | 20.42M | 24.85M | 20.46M | 15.39M | 15.15M | 9.00M | 5.35M | — |
| Long-Term Debt | — | — | — | — | 10.50M | — | — | — |
| Total Liabilities | 24.53M | 31.02M | 27.92M | 24.83M | 25.67M | 9.22M | 6.12M | — |
| Shareholders' Equity | 384.36M | 243.12M | 224.09M | 222.35M | 272.98M | 289.78M | -90.08M | -64.43M |
| Retained Earnings | -692.24M | -562.77M | -434.93M | -334.23M | -245.11M | -166.39M | -92.69M | — |
| Total Debt | — | — | — | — | 10.50M | — | — | — |
| Net Cash (Debt) | 281.49M | 255.96M | 208.19M | 206.27M | 226.48M | 293.60M | 89.16M | 42.64M |
| Shares Outstanding | 98.53M | 71.02M | 54.87M | 45.09M | 39.43M | 36.67M | 1.98M | — |
This table shows 8 annual periods of Oric Pharmaceuticals's balance sheet, from FY 2025 back to FY 2018, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ORIC's reporting calendar. What is a balance sheet?